Mapping clinically significant lesions from mpMRI using convolution neural network: feasibility assessment in MRI-guided biopsy cases

Author(s):  
Joshua Pearlson ◽  
Franklin King
2012 ◽  
Vol 78 (10) ◽  
pp. 1087-1090 ◽  
Author(s):  
Christopher R. Oxner ◽  
Lalit Vora ◽  
John Yim ◽  
Laura Kruper ◽  
Joshua D.I. Ellenhorn

The use of magnetic resonance imaging (MRI) for the diagnosis and evaluation of breast lesions is still in evolution. The aim of this study was to evaluate the outcome of MR-guided biopsy for suspicious lesions seen on MRI but not visualized by mammography or ultrasound. A retrospective review was conducted on all patients undergoing MRI-guided core needle biopsy at a National Cancer Institute-designated comprehensive cancer center. Biopsies were performed using a 1.5-Tesla MR with a seven-channel breast coil taking six cores in a clock face configuration with a 10-gauge vacuum-assisted VACORA biopsy device. One hundred twenty-seven patients underwent 187 biopsies without major complication. The lesion size ranged from 4 to 12 mm. Pathology on MRI-guided core biopsy material revealed 126 (68%) benign lesions. Of these, 12 were intraductal papillomas and two were fibroadenomas. Sixty-one (32%) were deemed clinically significant and included the following pathology: invasive cancer 19 patients (10%), ductal carcinoma in situ (DCIS) in 25 patients (13%), atypical ductal hyperplasia (ADH) 15 patients (8%), and lobular carcinoma in situ in one patient (1%). There were two specimens upgraded from ADH to DCIS and one specimen that was biopsied was called ADH but there was no residual atypia on final pathology. With a median follow-up of 24 months, there were no patients with benign pathology returning with a clinically significant lesion later. MRI-guided biopsy provides an accurate and safe method for sampling suspicious lesions when no other reasonable means of biopsy is available. MRI-guided biopsy yielded clinically significant findings in approximately one-third of the sampled specimens. This technique can provide a good representative sample of clinically significant pathology. MRI-guided biopsy is a relatively new modality, which can provide a nonsurgical diagnostic specimen in the absence of mammographic or ultrasound findings.


2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Nicola Robertson ◽  
Caroline Moore ◽  
Arnauld Villers ◽  
Laurence Klotz ◽  
Mark Emberton

2020 ◽  
Vol 203 ◽  
pp. e850-e851
Author(s):  
Adam Kinnaird* ◽  
Alan Priester ◽  
Ryan Chuang ◽  
Danielle Barsa ◽  
Merdie Delfin ◽  
...  

2019 ◽  
Author(s):  
CHIEN WEI ◽  
Chi Chow Julie ◽  
Chou Willy

UNSTRUCTURED Backgrounds: Dengue fever (DF) is an important public health issue in Asia. However, the disease is extremely hard to detect using traditional dichotomous (i.e., absent vs. present) evaluations of symptoms. Convolution neural network (CNN), a well-established deep learning method, can improve prediction accuracy on account of its usage of a large number of parameters for modeling. Whether the HT person fit statistic can be combined with CNN to increase the prediction accuracy of the model and develop an application (APP) to detect DF in children remains unknown. Objectives: The aim of this study is to build a model for the automatic detection and classification of DF with symptoms to help patients, family members, and clinicians identify the disease at an early stage. Methods: We extracted 19 feature variables of DF-related symptoms from 177 pediatric patients (69 diagnosed with DF) using CNN to predict DF risk. The accuracy of two sets of characteristics (19 symptoms and four other variables, including person mean, standard deviation, and two HT-related statistics matched to DF+ and DF−) for predicting DF, were then compared. Data were separated into training and testing sets, and the former was used to predict the latter. We calculated the sensitivity (Sens), specificity (Spec), and area under the receiver operating characteristic curve (AUC) across studies for comparison. Results: We observed that (1) the 23-item model yields a higher accuracy rate (0.95) and AUC (0.94) than the 19-item model (accuracy = 0.92, AUC = 0.90) based on the 177-case training set; (2) the Sens values are almost higher than the corresponding Spec values (90% in 10 scenarios) for predicting DF; (3) the Sens and Spec values of the 23-item model are consistently higher than those of the 19-item model. An APP was subsequently designed to detect DF in children. Conclusion: The 23-item model yielded higher accuracy rates (0.95) and AUC (0.94) than the 19-item model (accuracy = 0.92, AUC = 0.90). An APP could be developed to help patients, family members, and clinicians discriminate DF from other febrile illnesses at an early stage.


Sign in / Sign up

Export Citation Format

Share Document